Composition : Phanylephrine Hydrochloride 5 mg + Dextromethorphan Hydrobromide 10 mg + Chlorpheniramine Maleate 2mg
Description
Composition: Phenylephrine Hydrochloride 5 mg + Dextromethorphan Hydrobromide 10 mg + Chlorpheniramine Maleate 2mg (oral suspension, Cranberry with Menthol Flavour, Sugar Free). In this combination, Phenylephrine (nasal decongestant), Dextromethorphan (centrally acting cough suppressant) and Chlorpheniramine Maleate (first-generation antihistamine) are paired so that their mechanisms work alongside one another.
Phenylephrine is an alpha-adrenergic agonist that relieves nasal congestion through vasoconstriction. Dextromethorphan is a centrally acting antitussive used for dry cough. Chlorpheniramine maleate is an H1-antihistamine that reduces sneezing, rhinorrhoea and itching.
TOSOUT-D is a prescription medicine from Aerochem Neutron's respiratory range, for use on the prescription of a registered medical practitioner.
· Dry (non-productive) cough
· Cough associated with common cold and allergy
· Nasal congestion and runny nose
Note: indications reflect established uses of the individual molecules; confirm against the CDSCO-approved label for this fixed-dose combination· Dry (non-productive) cough
· Cough associated with common cold and allergy
· Nasal congestion and runny nose
· Note: indications reflect established uses of the individual molecules; confirm against the CDSCO-approved label for this fixed-dose combination
Safety
· Contraindicated in patients with known hypersensitivity to any component.
· Sympathomimetic decongestants should be used with caution in hypertension, heart disease, hyperthyroidism, diabetes and prostatic enlargement, and are contraindicated with MAO inhibitors.
· Contraindicated with MAO inhibitors; risk of serotonin syndrome with serotonergic drugs. Not for productive cough.
· Sedating antihistamines may cause drowsiness and anticholinergic effects; caution with driving, alcohol, glaucoma and urinary retention.
· Pregnancy and lactation: use only if the prescriber judges the benefit to outweigh the risk.
Clinical Rationale: The mechanisms and labelled uses of phenylephrine, dextromethorphan, chlorpheniramine described here follow the US prescribing information (DailyMed). Use of the combination should follow the CDSCO-approved label for this fixed-dose combination.
References
· DailyMed (US NLM) prescribing information – phenylephrine: https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=PHENYLEPHRINE
· DailyMed (US NLM) prescribing information – dextromethorphan: https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=DEXTROMETHORPHAN
· DailyMed (US NLM) prescribing information – chlorpheniramine: https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=CHLORPHENIRAMINE
Verified product information, formulation specifications, and commercial supply pathways for registered healthcare professionals, institutions, and trade partners.
Review verified active composition, strength, dosage form, and packaging details on this page.
View SpecificationsRequest formulation literature, technical specifications, or product communication from our commercial team.
Submit Product EnquiryConnect regarding institutional supply requirements, trade distribution, or third-party contract manufacturing.
Commercial EnquiryThis product information is intended for registered healthcare professionals, medical practitioners, and authorized distribution partners. Product manufacturing is coordinated through eligible facility partners under applicable licences.
Request information about TOSOUT D for professional use.